Hospital & Healthcare Management April 26, 2024
Content Team HHMGlobal

In a conversation with David W. Gould, Chief Customer Officer at EncompaaS, we delve into the transformative potential of AI in pharmaceutical rebate contract management. EncompaaS is revolutionizing the industry by leveraging next-generation AI technologies to automate processes, streamline data management, and provide real-time insights. Through innovative solutions, EncompaaS aims to empower pharmaceutical companies to navigate complex contractual relationships, maximize revenue potential, and ultimately contribute to improving human health and productivity.”

1. Can you tell us a bit about EncompaaS and its mission in the pharmaceutical industry?

The one thing we know best about pharmaceutical manufacturing is that time to success and time to failure are the two most important metrics driving business processes and outcomes. The relationships and processes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Radiologist-founded startup Rad AI raises $50M in Series B financing
Can AI triage emergency room patients?
Microsoft to invest $3.3B in Wisconsin AI data center as Biden hits at Trump over jobs creation
Backpack Health Raises $14M for AI-Backed Youth Mental Health Platform
Quantum Computing May Boost AI Capabilities

Share This Article